Welcome to the e-CCO Library!

P775: Disease activity and treatment patterns of newly diagnosed adult patients with Crohn's disease in Japan: Interim analysis of inception cohort registry study of patients with Crohn's disease (iCREST-CD)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Shinzaki, S.(1)*;Matsuoka, K.(2);Fujii, T.(3);Okamoto, R.(3);Yamada, A.(2);Kunisaki, R.(4);Matsuura, M.(5);Watanabe, K.(1);Shiga, H.(6);Takatsu, N.(7);Bamba, S.(8);Mikami, Y.(9);Yamamoto, T.(10);Shimoyama, T.(10);Motoya, S.(11);Torisu, T.(12);Kobayashi, T.(13);Ohmiya, N.(14);Saruta, M.(15);Matsuda, K.(16);Matsumoto, T.(17);Nakase, H.(18);Maemoto, A.(19);Murata, Y.(20);Yoshigoe, S.(20);Tsuchiya, H.(20);Hisamatsu, T.(5);
Created: Friday, 14 July 2023, 11:12 AM
P775: Fibre intake is associated with microbiome changes in pediatric Crohn's disease patients following remission induction with exclusive enteral nutrition
Year: 2017
Source: ECCO '17 Barcelona
Authors:

MacLellan A.*1, Connors J.2, MacIntyre B.2, Douglas G.3, Dunn K.A.4, Bielawski J.P.4, Noble A.2, Mahdi G.2, Rashid M.2, Otley A.R.2, Cahill L.5, Langille M.G.3, Van Limbergen J.6

Created: Wednesday, 20 February 2019, 10:36 AM
P775: Finger clubbing and Crohn's disease: higher frequency in patients with upper GI lesions in a prospective study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Romeo1, B. Neri*1, E. Lolli1, E. Calabrese1, E. De Cristofaro1, C. Gesuale1, L. Biancone1

Created: Friday, 22 February 2019, 9:41 AM
P775: Usefulness of endoscopic balloon dilation for colorectal strictures in patients with Crohn’s disease who underwent administration of TNF-α inhibitor
Year: 2018
Source: ECCO '18 Vienna
Authors:

T. Takeda1*, F. Hirai1, S. Ishikawa2, Y. Yano2, K. Masahiro2, Y. Takada2, T. Beppu2, K. Yao3, T. Matsui2, T. Ueki2

Created: Thursday, 21 February 2019, 9:14 AM
P776 Hospital re-admission in patients with inflammatory bowel disease: what are the risk factors?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

R. Fromson, E. Johnson, E. Routledge, S. Jameie-Oskooei, W. Blad, R. Patel, V. Wong

Created: Thursday, 30 January 2020, 10:12 AM
P776: Dysbiosis in Nlrp6/Asc-deficient mice does not result from inflammasome deficiency
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Mamantopoulos M.1,2, Ronchi F.3, Van Hauwermeiren F.2,4, Vieira-Silva S.5,6, Yilmaz B.3, Martens L.2,4, Saeys Y.2,4, Drexler S.7, Yazdi A.8, Raes J.5,6, Lamkanfi M.2,4, McCoy K.3, Wullaert A.*2,4

Created: Wednesday, 20 February 2019, 10:36 AM
P776: Factors associated with quality of care perceived by patients in IBD units from Spain. Analysis from IQCARO project
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

F. Casellas1, D. Carpio2, M. Minguez3, I. Vera4, B. Juliá*5, L. Marin6, R. Saldaña7, L. Cea5, X. Calvet8

Created: Friday, 22 February 2019, 9:41 AM
P776: Ferric carboxymaltose therapy in IBD patients with iron deficient anaemia: Real-life data from Germany
Year: 2018
Source: ECCO '18 Vienna
Authors:

J. Stein1,2*, S. Vollmer3, W. Klemm4, K. Nip5, S. Weber-Mangal5, A. Dignass1,6

Created: Thursday, 21 February 2019, 9:14 AM
P776: Polymeric exclusive enteral nutrition induces biochemical remission in adults with active Crohn's Disease irrespective of disease location or concomitant steroid use
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kuo, H.(1)*;Tognolini, K.(2);Willmann, L.(1);Haig, A.(1);Subhaharan, D.(1);Mutsekwa, R.(2);Shukla, D.(1);Moattar, H.(1);Dorrington, A.(1);Ishaq, N.(1);Bhullar, M.(1);Edwards, J.(1);Mohsen, W.(1);Kakkadasam Ramaswamy, P.(1);
Created: Friday, 14 July 2023, 11:12 AM
P777 Clostridioides difficile infection in children with inflammatory bowel disease: A Canadian population-based study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

W. El-Matary1, A. Chandrakumar2, H. Zohni2

Created: Thursday, 30 January 2020, 10:12 AM
P777: Comparison of costs of different biologic therapies after dose optimisation
Year: 2018
Source: ECCO '18 Vienna
Authors:

V. Borzan1,2, V. Orsic Fric1,2*, B. Borzan2

Created: Thursday, 21 February 2019, 9:14 AM
P777: Deployment of an artificial intelligence tool for precision medicine in ulcerative colitis: Preliminary data from 8 globally distributed clinical sites
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Peyrin-Biroulet, L.(1)*;Rubin, D.(2);Weber, C.(3);Adsul, S.(4);Freire, M.(4);Biedermann, L.(5);Koelzer, V.(6);Bressler, B.(7);Xiong, W.(8);Niess, J.(9);Matthias Matter, M.M.(9);Kopylov, U.(10);Barshack, I.(11);Mayer, C.(11);Magro, F.(12);Carneiro, F.(13);Maharshak, N.(14);Greenberg, A.(15);Hart, S.(16);Dehmeshki, J.(17);Kubassova, O.(16);
Created: Friday, 14 July 2023, 11:12 AM
P777: The cancer incidence in paediatric onset inflammatory bowel disease: a population-based study from Denmark
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Malham*1, C. Jakobsen1,2, A. Paerregaard1, L. B. Riis3, K-L. Kolho4, V. Wewer1

Created: Friday, 22 February 2019, 9:41 AM
P777: Ursodeoxycholic acid and its taurine/glycine conjugated species reduce colitogenic dysbiosis and equally suppress experimental colitis in mice
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Van den Bossche L.*1, Hindryckx P.1, Devisscher L.1, Devriese S.1, Van Welden S.1, Holvoet T.1, Vilchez-Vargas R.2, Vital M.3, Pieper D.H.3, Vanden Bussche J.4, Vanhaecke L.4, Van de Wiele T.2, De Vos M.1, Laukens D.1

Created: Wednesday, 20 February 2019, 10:36 AM
P778 Longitudinal trajectory of fatigue in inflammatory bowel disease patients: a prospective study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

N. Borren1, M. Long2, J. van der Woude3, R. Sandler2, A. Ananthakrishnan1

Created: Thursday, 30 January 2020, 10:12 AM
P778: Effectiveness and safety of a second-line rescue therapy for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: García, M.J.(1)*;Riestra, S.(2);Amiot, A.(3);Julsgaard, M.(4);García de la Filia, I.(5);Calafat, M.(6);Aguas, M.(7);de la Peña, L.(8);Roig-Ramos, C.(9);Caballol, B.(10);Casanova, M.J.(11);Farkas, K.(12);Boysen, T.(13);Bujanda, L.(14);Cuarán, C.(15);Dobru, D.(16);Fousekis, F.(17);Gargallo-Puyuelo, C.J.(18);Savarino, E.(19);Calvet, X.(20);Huguet, J.M.(21);Kupcinskas, L.(22);López-Cardona, J.(23);Raine, T.(24);van Oostrom, J.(25);P. Gisbert*, J.(11);Chaparro*, M.(11);
Created: Friday, 14 July 2023, 11:12 AM
P778: Microbial characterization of paediatric inflammatory bowel disease and stratification into disease severity groups
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Olbjørn C.*1,2, Cvancarova Småstuen M.3, Casén C.4, Nakstad B.1,2, Lindahl T.4, Rove J.B.1, Thiis-Evensen E.5, Vatn M.H.6, Perminow G.7

Created: Wednesday, 20 February 2019, 10:36 AM
P778: Real-world drug treatment costs for ulcerative colitis and Crohn’s disease patients treated with vedolizumab vs. anti-TNFα: Results from a German retrospective chart review study
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Campbell-Hill1*, D. Stein2, M. Soni2, C. Coombs3, B. Ratsch4, J.M. Khalid1, K. Minda5

Created: Thursday, 21 February 2019, 9:14 AM
P778: Risk of cancer in paediatric onset inflammatory bowel disease: a nationwide cohort study 1977–2014
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

V. S. Kjærgaard1,2, C. B. Jensen1, J. Burisch1,3, K. Allin1, T. Jess*1

Created: Friday, 22 February 2019, 9:41 AM
P779 Intestinal cancer associated with Crohn’s disease: difference between those with short duration and those with long duration
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Shinozaki, R. Takahashi

Created: Thursday, 30 January 2020, 10:12 AM